WO2013153161A3 - Polymorph of rilpivirine hydrochloride - Google Patents
Polymorph of rilpivirine hydrochloride Download PDFInfo
- Publication number
- WO2013153161A3 WO2013153161A3 PCT/EP2013/057596 EP2013057596W WO2013153161A3 WO 2013153161 A3 WO2013153161 A3 WO 2013153161A3 EP 2013057596 W EP2013057596 W EP 2013057596W WO 2013153161 A3 WO2013153161 A3 WO 2013153161A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymorph
- present
- rilpivirine hydrochloride
- novel
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a novel polymorph and to novel solvates of rilpivirine hydrochloride, as well as to their preparation. The novel solvates are valuable intermediates for the preparation of the novel polymorph of rilpivirine hydrochloride of the present invention. Moreover the present invention relates to the use of the novel polymorph for the preparation of a medicament. In addition the present invention relates to pharmaceutical compositions comprising an effective amount of the novel polymorph of rilpivirine hydrochloride and to methods of preparing the same. Finally the present invention relates to pharmaceutical combinations comprising an effective amount of the novel polymorph of rilpivirine hydrochloride and additional therapeutic agents.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12163720 | 2012-04-11 | ||
EP12163720.1 | 2012-04-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013153161A2 WO2013153161A2 (en) | 2013-10-17 |
WO2013153161A3 true WO2013153161A3 (en) | 2013-12-05 |
Family
ID=48050762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2013/057596 WO2013153161A2 (en) | 2012-04-11 | 2013-04-11 | Novel polymorph of rilpivirine hydrochloride |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013153161A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015136294A1 (en) * | 2014-03-13 | 2015-09-17 | Cipla Limited | Pharmaceutical composittion comprising rilpivirine |
WO2021104487A1 (en) | 2019-11-29 | 2021-06-03 | Aptorum Therapeutics Limited | Composition including rilpivirine and use thereof for treating tumors or cancer |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1632232A1 (en) * | 2004-09-02 | 2006-03-08 | Janssen Pharmaceutica N.V. | Salt of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile |
WO2012125993A1 (en) * | 2011-03-17 | 2012-09-20 | Teva Pharmaceutical Industries Ltd. | Solid state forms of rilpivirine base, and rilipivirine salts |
WO2012143937A2 (en) * | 2011-04-15 | 2012-10-26 | Emcure Pharmaceuticals Limited | An improved rilpivirine process |
WO2012147091A2 (en) * | 2011-04-25 | 2012-11-01 | Hetero Research Foundation | Process for rilpivirine |
WO2013038425A1 (en) * | 2011-09-16 | 2013-03-21 | Hetero Research Foundation | Rilpivirine hydrochloride |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3429B1 (en) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | Hiv inhibiting pyrimidines derivatives |
-
2013
- 2013-04-11 WO PCT/EP2013/057596 patent/WO2013153161A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1632232A1 (en) * | 2004-09-02 | 2006-03-08 | Janssen Pharmaceutica N.V. | Salt of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile |
WO2012125993A1 (en) * | 2011-03-17 | 2012-09-20 | Teva Pharmaceutical Industries Ltd. | Solid state forms of rilpivirine base, and rilipivirine salts |
WO2012143937A2 (en) * | 2011-04-15 | 2012-10-26 | Emcure Pharmaceuticals Limited | An improved rilpivirine process |
WO2012147091A2 (en) * | 2011-04-25 | 2012-11-01 | Hetero Research Foundation | Process for rilpivirine |
WO2013038425A1 (en) * | 2011-09-16 | 2013-03-21 | Hetero Research Foundation | Rilpivirine hydrochloride |
Also Published As
Publication number | Publication date |
---|---|
WO2013153161A2 (en) | 2013-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012154679A8 (en) | Tricyclic pyrazole sulfonamide compounds and methods of making and using same | |
EA033544B1 (en) | Pyridone derivatives as rearranged during transfection (ret) kinase inhibitors | |
TN2012000414A1 (en) | Forms of rifaximin and uses thereof | |
WO2013004995A8 (en) | Pyrimidinone compounds and their use | |
WO2012065022A3 (en) | Spiro-oxindole mdm2 antagonists | |
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
WO2013158928A3 (en) | Chemosensory receptor ligand-based therapies | |
IN2015DN01119A (en) | ||
WO2014070991A3 (en) | Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists | |
WO2012032209A3 (en) | Pharmaceutical composition for the treatment of dry eye | |
MX347734B (en) | S100a4 antibodies and therapeutic uses thereof. | |
WO2012135615A3 (en) | Enopeptins, uses thereof, and methods of synthesis thereto | |
PH12014501195A1 (en) | Novel 2h-indazoles as ep2, receptor antagonists | |
IL223872A (en) | Pyrazoloquinolines and intermediate compounds, process for their preparation, use thereof and medicaments and pharmaceutical compositions comprising them | |
MX2014010433A (en) | Novel crystalline form of sitagliptin sulfate. | |
WO2013128379A3 (en) | Crystalline polymorphic forms of linagliptin | |
UA117154C2 (en) | S1p3 antagonists | |
HK1188791A1 (en) | Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these | |
IL225105A (en) | Heterocyclic compounds, process for their preparation, pharmaceutical compositions comprising them and use thereof for the preparation of medicaments | |
EP2701689A4 (en) | Pharmaceutical compositions of raltegravir, methods of preparation and use thereof | |
EP2871187A4 (en) | Novel compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient | |
WO2013153161A3 (en) | Polymorph of rilpivirine hydrochloride | |
MX2013003859A (en) | Picropodophyllin polymorphs b or c for use in cancer therapy. | |
WO2014159501A3 (en) | Processes for preparing tetrahydroisoquinolines | |
MX367773B (en) | Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13714974 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13714974 Country of ref document: EP Kind code of ref document: A2 |